NCT05594745View on ClinicalTrials.gov

Treatment Regimens in Meibomian Gland Dysfunction

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

March 2, 2021

Primary Completion Date

January 21, 2023

Study Completion Date

January 21, 2023

Conditions
Dry Eye Syndromes
Interventions
DRUG

Lifitegrast Ophthalmic

eyedrop

DRUG

Systane Free

eyedrop

DEVICE

Lipiflow

thermal pulsation

Trial Locations (1)

64111

joseph Tauber, Kansas City

All Listed Sponsors
lead

Tauber Eye Center

OTHER

NCT05594745 - Treatment Regimens in Meibomian Gland Dysfunction | Biotech Hunter | Biotech Hunter